Join to View Full Profile
2401 W Belvedere AveBaltimore, MD 21215
Phone+1 410-601-5864
Dr. Bamme is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Yevgeniya Bamme is a specialist in Pediatric Hematology and Oncology based in Baltimore, MD. She completed her medical education at Ross University School of Medicine, followed by a residency in Pediatrics and a Chief Residency at Albany Medical Center. Dr. Bamme further specialized through a fellowship in Pediatric Hematology/Oncology at Penn State Milton S Hershey Medical Center. Her research includes publications on prenatal cell-free fetal DNA testing, treatments for high-grade neuroendocrine carcinoma, and therapeutic approaches for leukemia, with some of her work being cited by other professionals in the field.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Albany Medical CenterChief Residency, Pediatrics, 2016 - 2017- Albany Medical CenterResidency, Pediatrics, 2013 - 2016
Ross University School of MedicineClass of 2012
Certifications & Licensure
MD State Medical License 2020 - 2026
NY State Medical License 2016 - 2024
PA State Medical License 2017 - 2020
RI State Medical License 2015 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 15 citationsCell-free fetal DNA testing and its correlation with prenatal indicationsJingwei Wang, Yongnan Lyu, Bin Qiao, Yan Li, Yan Zhang
BMC Pregnancy and Childbirth. 2021-08-24 - Metastatic high-grade neuroendocrine carcinoma of unknown primary: Successful treatment in a child with extensive bone marrow involvement.Yevgeniya Bamme, Smita Dandekar
Pediatric Blood & Cancer. 2021-05-31 - 13 citationsDual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemiaZheng Ge, Chunhua Song, Yali Ding, Bi-Hua Tan, Dhimant Desai
Leukemia. 2021-02-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
